Peptide-based vectors have obtained focus for their specificity in binding to receptors overexpressed in breast most cancers cells, perhaps beating issues linked to reduced internalization. These techniques open new avenues for treatments personalized to combat particular breast most cancers subtypes and glioblastoma by honing in on integrins, f